186 related articles for article (PubMed ID: 15025678)
1. Correlates of total homocysteine plasma concentration in type 2 diabetes.
Russo GT; Di Benedetto A; Giorda C; Alessi E; Crisafulli G; Ientile R; Di Cesare E; Jacques PF; Raimondo G; Cucinotta D
Eur J Clin Invest; 2004 Mar; 34(3):197-204. PubMed ID: 15025678
[TBL] [Abstract][Full Text] [Related]
2. Homocysteine, folate, methylene tetrahydrofolate reductase genotype and vascular morbidity in diabetic subjects.
Kaye JM; Stanton KG; McCann VJ; Vasikaran SD; Burke V; Taylor RR; van Bockxmeer FM
Clin Sci (Lond); 2002 Jun; 102(6):631-7. PubMed ID: 12049616
[TBL] [Abstract][Full Text] [Related]
3. Reduced serum homocysteine levels in type 2 diabetes.
Mazza A; Bossone E; Mazza F; Distante A
Nutr Metab Cardiovasc Dis; 2005 Apr; 15(2):118-24. PubMed ID: 15871860
[TBL] [Abstract][Full Text] [Related]
4. Plasma total homocysteine levels in children with type 1 diabetes: relationship with vitamin status, methylene tetrahydrofolate reductase genotype, disease parameters and coronary risk factors.
Dinleyici EC; Kirel B; Alatas O; Muslumanoglu H; Kilic Z; Dogruel N
J Trop Pediatr; 2006 Aug; 52(4):260-6. PubMed ID: 16401615
[TBL] [Abstract][Full Text] [Related]
5. Thermolabile methylenetetrahydrofolate reductase enzyme genotype is frequent in type 2 diabetic patients with normal fasting homocysteine levels.
Tutuncu NB; Erbas T; Alikasifoglu M; Tuncbilek E
J Intern Med; 2005 May; 257(5):446-53. PubMed ID: 15836661
[TBL] [Abstract][Full Text] [Related]
6. Factors explaining the difference of total homocysteine between men and women in the European Investigation Into Cancer and Nutrition Potsdam study.
Dierkes J; Jeckel A; Ambrosch A; Westphal S; Luley C; Boeing H
Metabolism; 2001 Jun; 50(6):640-5. PubMed ID: 11398138
[TBL] [Abstract][Full Text] [Related]
7. Plasma total homocysteine levels and methylenetetrahydrofolate reductase gene polymorphism in patients with type 2 diabetes mellitus.
Soares AL; Fernandes AP; Cardoso JE; Sousa MO; Lasmar MC; Novelli BA; Lages GF; Dusse LM; Vieira LM; Lwaleed BA; Carvalho MG
Pathophysiol Haemost Thromb; 2008; 36(5):275-81. PubMed ID: 19996639
[TBL] [Abstract][Full Text] [Related]
8. Mild hyperhomocysteinemia, C677T polymorphism on methylenetetrahydrofolate reductase gene and the risk of macroangiopathy in type 2 diabetes: a prospective study.
Russo GT; Di Benedetto A; Magazzù D; Giandalia A; Giorda CB; Ientile R; Previti M; Di Cesare E; Cucinotta D
Acta Diabetol; 2011 Jun; 48(2):95-101. PubMed ID: 19937354
[TBL] [Abstract][Full Text] [Related]
9. Physiologic changes in homocysteine metabolism in pregnancy: a longitudinal study in Spain.
Ubeda N; Reyes L; González-Medina A; Alonso-Aperte E; Varela-Moreiras G
Nutrition; 2011 Sep; 27(9):925-30. PubMed ID: 21367581
[TBL] [Abstract][Full Text] [Related]
10. Plasma homocysteine after insulin infusion in type II diabetic patients with and without methionine intolerance.
Ventura P; Panini R; Emiliani S; Salvioli G
Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):44-51. PubMed ID: 14758571
[TBL] [Abstract][Full Text] [Related]
11. Gene--nutrition interactions in coronary artery disease: correlation between the MTHFR C677T polymorphism and folate and homocysteine status in a Korean population.
Huh HJ; Chi HS; Shim EH; Jang S; Park CJ
Thromb Res; 2006; 117(5):501-6. PubMed ID: 15935452
[TBL] [Abstract][Full Text] [Related]
12. Contribution of thermolabile methylenetetrahydrofolate reductase variant to total plasma homocysteine levels in healthy men and women. Inter99 (2).
Husemoen LL; Thomsen TF; Fenger M; Jørgensen HL; Jørgensen T
Genet Epidemiol; 2003 May; 24(4):322-30. PubMed ID: 12687650
[TBL] [Abstract][Full Text] [Related]
13. Association of plasma homocysteine with serum interleukin-6 and C-peptide levels in patients with type 2 diabetes.
Araki A; Hosoi T; Orimo H; Ito H
Metabolism; 2005 Jun; 54(6):809-14. PubMed ID: 15931619
[TBL] [Abstract][Full Text] [Related]
14. Reduced total plasma homocyst(e)ine in children and adolescents with type 1 diabetes.
Wiltshire E; Thomas DW; Baghurst P; Couper J
J Pediatr; 2001 Jun; 138(6):888-93. PubMed ID: 11391334
[TBL] [Abstract][Full Text] [Related]
15. The MTHFR CT polymorphism confers a high risk for stroke in both homozygous and heterozygous T allele carriers with Type 2 diabetes.
Hermans MP; Gala JL; Buysschaert M
Diabet Med; 2006 May; 23(5):529-36. PubMed ID: 16681562
[TBL] [Abstract][Full Text] [Related]
16. Retinal vein occlusion, homocysteine, and methylene tetrahydrofolate reductase genotype.
McGimpsey SJ; Woodside JV; Bamford L; Gilchrist SE; Graydon R; McKeeman GC; Young IS; Hughes AE; Patterson CC; O'Reilly D; McGibbon D; Chakravarthy U
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4712-6. PubMed ID: 16303969
[TBL] [Abstract][Full Text] [Related]
17. Serum homocysteine, folate, vitamin B12 levels and arterial stiffness in diabetic patients: which of them is really important in atherogenesis?
Shargorodsky M; Boaz M; Pasternak S; Hanah R; Matas Z; Fux A; Beigel Y; Mashavi M
Diabetes Metab Res Rev; 2009 Jan; 25(1):70-5. PubMed ID: 19065546
[TBL] [Abstract][Full Text] [Related]
18. Lack of association between carotid intima-media thickness and methylenetetrahydrofolate reductase gene polymorphism or serum homocysteine in non-insulin-dependent diabetes mellitus.
Mazza A; Motti C; Nulli A; Marra G; Gnasso A; Pastore A; Federici G; Cortese C
Metabolism; 2000 Jun; 49(6):718-23. PubMed ID: 10877195
[TBL] [Abstract][Full Text] [Related]
19. Plasma total homocysteine level and bone mineral density: the Hordaland Homocysteine Study.
Gjesdal CG; Vollset SE; Ueland PM; Refsum H; Drevon CA; Gjessing HK; Tell GS
Arch Intern Med; 2006 Jan; 166(1):88-94. PubMed ID: 16401815
[TBL] [Abstract][Full Text] [Related]
20. Plasma homocysteine and microvascular complications in type 1 diabetes.
Vaccaro O; Perna AF; Mancini FP; Iovine C; Cuomo V; Sacco M; Tufano A; Rivellese AA; Ingrosso D; Riccardi G
Nutr Metab Cardiovasc Dis; 2000 Dec; 10(6):297-304. PubMed ID: 11302003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
